Tampon Global Regulatory overview Erly Evita Product Safety & Regulatory Affairs Procter & Gamble Far East Inc. Kobe Technical Center, Japan.

Slides:



Advertisements
Similar presentations
Personal Finance Product Labels. Food Products Required Information by the FDA Common name Form of food (whole, chopped, diced, etc) Net weight or volume.
Advertisements

Australian Guidance Document Number xx Cathy Thomas Professional Representation OT Australia WA.
@ PMCQ U October 19, Agenda l What is Advertising? l Pre-Launch Activities You Can Do l PAAB pre-NOC Meeting/Review policy.
510k Submission Overview Myraqa, Inc. August 22, 2012.
GHS STOCKTAKING WORKSHOP FOR SOUTHEAST, EAST, AND CENTRAL ASIA Siang –Hee Tan Executive Director Beijing, Sept th 2010.
Federal agency for medicines and health products EXCIPIENTS IN THE LABLE AND PACKAGE LEAFLET OF HOMEOPATHIC MEDICINAL PRODUCTS Patricia Bodart – 23 October.
© 2005 Notification and Reporting on Food Incidents: Irish Approach Food & Drugs Authority Bangkok Thailand Dorothy Guina-Dornan.
These Facts Should Be Known by all Women. What is a Tampon? Absorbent Core Cotton/Rayon/Viscose Fluff Withdrawal Cord Cotton/Polyester String Sewed to.
External Defibrillators: Recalls, Inspections, and the Quality System Regulation Melissa Torres Office of Compliance December 15, 2010.
Industry Trends and Tools for Generic Product Selection KATE KUHRT SHANGHAI JUNE 19-21, 2007.
1 Health Accounts Meeting 30 Sept – 1 October 2004 Developing Activity and Product Classifications for the Modern Economy: What about health services?
+ Medical Devices Approval Process. + Objectives Define a medical device Be familiar with the classification system for medical devices Understand the.
Weaving regulations into sound value analysis processes Barbara Strain, MA, SM(ASCP) Director Value Management University of Virginia Health System.
Critical Success Factors for the Korean Generic and API Industry in a post FTA Environment DAVID HARDING SEOUL JUNE 28-29, 2007.
FDA MedWatch and Patient Safety. Dietary Supplement and Nonprescription Drug Consumer Protection Act of 2006  The Act defines a ‘serious adverse event’
FDA Resources and Meetings FDA/EMA Orphan Designation and Grant Workshop Silver Spring, Maryland FDA Campus (White Oak) October 12, 2012 Bill Sutton Deputy.
Ashland Specialty Ingredients IFAC’s cGMP Audit Guide How the Food Ingredient Industry has Responded to FSMA and Food Safety Audits Priscilla Zawislak.
Introduce on Imported Foods System in Korea - Under The Food Sanitation Act - Korea Food and Drug Administration.
Standardization and Legislation of Medical equipment
New Zealand Medicines and Medical Devices Safety Authority A business unit of the Ministry of Health.
FDA Regulatory review in Minutes: What Product Development Executives Need-to-Know. Specifically, frequent causes of recalls and related areas that investigators.
Cavendish Scott, Inc. 1 Regulatory and Statutory Compliance: It’s Everybody’s Business! Diana Lough Cavendish Scott, Inc.
How to Register A Foreign Medical Device. SFDA Approval Documents Preparation Translation Create a Chinese Registration Standard Safety Testing in an.
Improving Access and Quality Use of Medicines in Palliative Care within National Drug Policy, Regulatory, and Funding Frameworks Debra Rowett, Tania Shelby-James,
Towards ISO Standards for AD syringes: Update from WHO Gerald Verollet World Health Organization 3rd SIGN Meeting - New Delhi.
TECHNICAL REQUIREMENTS FOR MINOR APPLICATIONS E MOKANTLA 3 SEPTEMBER 2013.
Registering a Foreign Medical Device in China Prepared by: Diversity Medical Services A Division of Shanghai Jian Tong Medical Equipment Company Ltd.
Proposed Rule for Preventive Controls for Animal Food.
Proposed Rule: 21 CFR 507 Proposed Rule for Preventive Controls for Animal Food 1.
Malaysia Update on “draft” proposal for the Environmentally Hazardous Substance (“EHS”) Notification and Registration Scheme.
FDA Regulatory and Compliance Symposium
REGULATION OF MEDICAL DEVICES INNOVATION TUĞÇE YAŞAR
GMP- A Regulatory Perspective. Regulatory Perspective in entering Global Pharma Markets.
Non Prescription Product Benefits
Global Lauric Acid Market Analysis Report 2014: Radiant Insights, Inc. TELEPHONE:
Global Suspension PTFE resin Industry Analysis Report 2014: Radiant Insights, Inc. TELEPHONE:
VICH General Principles and current update of VICH Outreach Forum activity 1.
By Lynsey Grove, Ian Cameron, and Maggie Bissell.
Center for Food Safety and Applied Nutrition Systems Recognition Import System Public Meeting March 21, 2016 Caroline Smith DeWaal International Food Safety.
Copyright  2004 McGraw-Hill Australia Pty Ltd PPTs t/a Consumer Behaviour 4e by Neal, Quester, Hawkins 18–1 Chapter 18Consumers and Society Role of consumerism.
T Mr.Willy Musinguzi, EAC. .Overview of EAC SQMT Infrastructure How EAC standards are Harmonized and Implemented How EAC Quality Infrastructure relates.
Regulatory Writing and Publishing Leads Global Regulatory Outsourcing Market – Trends and Forecast
Waiving TABST for vaccines Argentina: Not an allowed procedure today Require batch safety tests in laboratory animals, repeated by authorities Currently.
1 Improving the agenda for SWITCH for nonprescription Medicines Sheila Kelly WSMI September 2015.
U.S. Consumer Product Safety Commission U.S. Consumer Product Safety Commission Richard O’Brien, Director Roberta Telles, Program Manager Office of International.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Conductive Textiles Market Products, Applications & regional performance.
Global UHT Milk Market Expected to Reach 139 Billion litres by 2022.
Regulatory Updates Health Sciences Authority Singapore
Potential Impact on the Cotton Industry
Global Cell Phone Camera Module Market By Countries (United States, Germany, Japan and China) Research Report 2016.
EU tobacco and nicotine regulations - general aspects
Transboundary movement of used batteries of used lead batteries, in draft Guidelines for environmentally sound management of used lead batteries Jaromír.
Director, Asia Pacific Japan and U.S. Clinical Operations
Conductive Textiles Global Market Professional Survey Report 2017.
Introduction to the Italian Cosmetic System
HIMSS STANDARDS INITIATIVES
The EAC Quality Infrastructure and WTO TBT Agreement.
Global Panthenol Market Professional Survey Report 2017.
MEDICAL DEVICES DRUGS ECUADOR REGULATION.
MEDICAL PLASTICS MARKET Industry Survey, Growth, Competitive Landscape and Forecasts to 2023 PREPARED BY Market Research Future (Part of Wantstats.
Business seminar on export to Europe
Combination products The paradigm shift
Chemical substances self – classification issues Lithuanian approach
Melanie Cummings Regulatory Specialist
FDA Resources and Meetings
Ministry of Health Malaysia VOLUNTARY REGISTRATION FOR MEDICAL DEVICES ESTABLISHMENTS MeDVER Ministry of Health Malaysia.
National Medicines Policies
MEDICAL DEVICES CONTROL SYSTEM IN INDONESIA
Dr Manisha Shridhar Regional Advisor WHO-SEARO
National Medicines Policies
Presentation transcript:

Tampon Global Regulatory overview Erly Evita Product Safety & Regulatory Affairs Procter & Gamble Far East Inc. Kobe Technical Center, Japan

Agenda Regulatory Classification and registration Raw Material requirements Finished Product requirements Requirements to manage mTSS

Regulatory classification & registration United States, Canada: Medical Device (MD) class Ⅱ - registration needed Europe: Household product (Article) – no registration Japan: MD Class I (lowest class, reclassified from class II) – no registration (notification only) Australia: Therapeutic goods - registration needed Korea: Quasi Drug – registration needed China: disposable sanitary products – no registration Other Asia countries (Phil., Sing, Mal, ): general/paper/cosmetics – not regulated – no registration

Raw materials requirements Korea: approved specification for certain materials Other countries (US, Canada, Europe, Japan) : none

Finished Products Requirements Absorbency classification - Test method: syngyna -Regulated by US (FDA), Europe (EDANA, industry association), Australia (TGA), Japan (MHLW), Korea (KFDA) -China and other Asia countries: no specific requirements

Finished Product Requirements (cont.) Micro requirements: –US, Canada, Europe: none –Japan: No requirements. Japan MHLW verbally confirmed agreement to eliminate sterilization requirements from product standard. –Australia: total viable bacteria 1000 cfu, as precaution measure during manufacturing. –China : bacteria cfu; fungi – 100cfu (market not developed - under other sanitary products definition)

Finished Product Requirements (cont.) Rational why micro requirements not needed in the US and Europe (and Japan): –Non sterilized tampons are not cause of infection by toxigenic staph. aureus –Hygienic Manufacturing Standard requirements –Finished products contain so little water and nutrients that bacteria don’t multiply or grow during storage

Finished Products Requirements (cont.) Other quality related requirements: – Australia: withdrawal cord pull, water repellency. –Japan (Industry aligned - “final draft”): withdrawal cord, coloring matter, acid alkali –Korea: foreign material, dyes, acid alkali, fluorescence, absorption rate, fiber shed, withdrawal cord, blended cotton fiber composition

Requirements to manage mTSS US, Canada, Europe (EDANA Code of Practice), Japan, Australia & Korea –TSS Labeling –Absorbency labeling

Requirements to manage mTSS (cont.) TSS education of consumers - include elements of health relevant information on tampon packages –Each package must notify consumer that the pack contains important information regarding mTSS, a rare but serious illness –The notice should advise the user to read and save the leaflet TSS education of consumers and health professionals (e.g., website, school education programs) –provide relevant information on TSS to raise awareness of the important aspects of this rare but serious illness

Requirements to manage mTSS (cont.) TSS labeling –On the outside of the package TSS warning – “Attention…” –In the leaflet – TSS health information Inform consumers about TSS – definition and etiology Inform consumers that TSS is potentially fatal Provide full description of symptoms of TSS Instruct users to consult a doctor if the symptoms of TSS occur, to remove the tampon, and inform doctor that they are menstruating Advise women that if they have had TSS they should consult a doctor before future use.

Requirements to manage mTSS (cont.) Absorbency labeling –On the outside of the package Labeled with droplets indicating range of Syngina absorbency –In the leaflet Include a chart that links absorbency droplets to ranges of Syngina absorbency and to menstrual flow Advise women to use the lowest absorbency/size to suit their flow Note: Korea – not specifically required

Thank you